BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 24563280)

  • 1. The association of Crk-like adapter protein with poor prognosis in glioma patients.
    Yao C; Lv S; Han M; Zhang J; Zhang Y; Zhang L; Yi R; Zhuang D; Wu J
    Tumour Biol; 2014 Jun; 35(6):5695-700. PubMed ID: 24563280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The correlation of bone morphogenetic protein 2 with poor prognosis in glioma patients.
    Yang X; Li D; Cheng S; Fan K; Sheng L; Zhang J; Feng B; Xu Z
    Tumour Biol; 2014 Nov; 35(11):11091-5. PubMed ID: 25099618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of YAP1 and pSTAT3-S727 and their prognostic value in glioma.
    Sang W; Xue J; Su LP; Gulinar A; Wang Q; Zhai YY; Hu YR; Gao HX; Li X; Li QX; Zhang W
    J Clin Pathol; 2021 Aug; 74(8):513-521. PubMed ID: 33020176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncogenic reg IV is a novel prognostic marker for glioma patient survival.
    Wang Q; Deng J; Yuan J; Wang L; Zhao Z; He S; Zhang Y; Tu Y
    Diagn Pathol; 2012 Jun; 7():69. PubMed ID: 22713481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Periostin is a new potential prognostic biomarker for glioma.
    Tian B; Zhang Y; Zhang J
    Tumour Biol; 2014 Jun; 35(6):5877-83. PubMed ID: 24719188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High level of Sema3C is associated with glioma malignancy.
    Vaitkienė P; Skiriutė D; Steponaitis G; Skauminas K; Tamašauskas A; Kazlauskas A
    Diagn Pathol; 2015 Jun; 10():58. PubMed ID: 26032848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical significance of FOXP3 expression in human gliomas.
    Wang L; Zhang B; Xu X; Zhang S; Yan X; Kong F; Feng X; Wang J
    Clin Transl Oncol; 2014 Jan; 16(1):36-43. PubMed ID: 23579918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RIZ1: a potential tumor suppressor in glioma.
    Zhang C; Zhu Q; He H; Jiang L; Qiang Q; Hu L; Hu G; Jiang Y; Ding X; Lu Y
    BMC Cancer; 2015 Dec; 15():990. PubMed ID: 26690953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Syndecan-1 expression in human glioma is correlated with advanced tumor progression and poor prognosis.
    Xu Y; Yuan J; Zhang Z; Lin L; Xu S
    Mol Biol Rep; 2012 Sep; 39(9):8979-85. PubMed ID: 22714920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of pathology and survival by FDG PET in gliomas.
    Padma MV; Said S; Jacobs M; Hwang DR; Dunigan K; Satter M; Christian B; Ruppert J; Bernstein T; Kraus G; Mantil JC
    J Neurooncol; 2003 Sep; 64(3):227-37. PubMed ID: 14558598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CrkL meditates CCL20/CCR6-induced EMT in gastric cancer.
    Han G; Wu D; Yang Y; Li Z; Zhang J; Li C
    Cytokine; 2015 Dec; 76(2):163-169. PubMed ID: 26044596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of CRKL correlates with poor prognosis and cell proliferation in non-small cell lung cancer.
    Wang Y; Dong QZ; Fu L; Stoecker M; Wang E; Wang EH
    Mol Carcinog; 2013 Nov; 52(11):890-9. PubMed ID: 22753141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Up-Regulation of Long Non-Coding RNA AB073614 Predicts a Poor Prognosis in Patients with Glioma.
    Hu L; Lv QL; Chen SH; Sun B; Qu Q; Cheng L; Guo Y; Zhou HH; Fan L
    Int J Environ Res Public Health; 2016 Apr; 13(4):433. PubMed ID: 27104549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expression of cyclin D1 in brain gliomas and its significance].
    Tan PG; Xing Z; Li ZQ
    Ai Zheng; 2004 Jan; 23(1):63-5. PubMed ID: 14720377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression level of human miR-34a correlates with glioma grade and prognosis.
    Gao H; Zhao H; Xiang W
    J Neurooncol; 2013 Jun; 113(2):221-8. PubMed ID: 23529798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The incidence, correlation with tumor-infiltrating inflammation, and prognosis of phosphorylated STAT3 expression in human gliomas.
    Abou-Ghazal M; Yang DS; Qiao W; Reina-Ortiz C; Wei J; Kong LY; Fuller GN; Hiraoka N; Priebe W; Sawaya R; Heimberger AB
    Clin Cancer Res; 2008 Dec; 14(24):8228-35. PubMed ID: 19088040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of CCL20 and its receptor CCR6 predicts poor clinical prognosis in human gliomas.
    Wang L; Qin H; Li L; Zhang Y; Tu Y; Feng F; Ji P; Zhang J; Li G; Zhao Z; Gao G
    Med Oncol; 2012 Dec; 29(5):3491-7. PubMed ID: 22926920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PinX1 is up-regulated and associated with poor patients' survival in gliomas.
    Bai J; Chen YS; Mei PJ; Liu QH; Du Y; Zheng JN
    Int J Clin Exp Pathol; 2015; 8(6):6952-9. PubMed ID: 26261583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prognostic value of clinical factors and cancer stem cell-related markers in gliomas.
    Dahlrot RH
    Dan Med J; 2014 Oct; 61(10):B4944. PubMed ID: 25283629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined detection of Gab1 and Gab2 expression predicts clinical outcome of patients with glioma.
    Liu H; Li G; Zeng W; Zhang P; Fan F; Tu Y; Zhang Y
    Med Oncol; 2014 Aug; 31(8):77. PubMed ID: 24998422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.